Clinical Trials on Contrast Agent in India

Total 12 results

Iladevi Cataract and IOL Research Center

Completed

Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation

Contrast Sensitivity

India
Dr. Krupa NC

Completed

Anticaries Effect of Xylitol,Probiotic and Chlorhexidine Mouth Rinses Among Individuals at High Risk (AEXPC)

Cariostatic Agents | Mouthwashes

India
GlaxoSmithKline

Completed

Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions

Antifungal Agents

India
Pfizer

Completed

A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Dermatitis, Contact

India
Postgraduate Institute of Medical Education and...

Unknown

HCV RAS Testing in Public Health Programs (RAS-HCV)

Hepatitis C | Public Health | Direct Acting Antiviral Agents | Resistance Associated Substitutions

India
Bayer

Recruiting

A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)

Children | Contrast Enhancement in Magnetic Resonance Imaging

United States, Japan, China, Italy, Czechia, Canada, Poland, Argentina, Bulgaria, Belgium, Germany, Sweden, Hungary
Jyoti Clinical and Pathological Laboratory

Completed

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs

Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents

India
Postgraduate Institute of Medical Education and...

Recruiting

Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients

Acute-On-Chronic Liver Failure | Mycoses | Invasive Fungal Infections | Antifungal Agents

India
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)

Contrast Enhancement in Magnetic Resonance Imaging | Central Nervous System Pathology

France, Turkey, Czechia, China, Japan, United States, United Kingdom, Italy, Korea, Republic of, Germany, Bulgaria, Hungary, Argentina, Canada, Sweden
Indian Council of Medical Research
King George's Medical University; Lady Hardinge Medical College; Postgraduate... and other collaborators

Completed

7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis

Recurrence | Anti-bacterial Agents | Neonatal SEPSIS | Infant, Newborn

India
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)

Contrast Enhancement in Magnetic Resonance Imaging | Non-central Nervous System Pathology

United States, Sweden, Japan, Czechia, China, Hungary, Poland, Italy, United Kingdom, Turkey, Korea, Republic of, Germany, Taiwan, France, Argentina, Bulgaria, Canada
The Aurum Institute NPC
Johns Hopkins University

Recruiting

Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients (1 to 3)

Tuberculosis | HIV Seropositivity | Household Contact

South Africa, India, Indonesia, Mozambique

Clinical Trials on Contrast Agent in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations